A carregar...
From Bench to FDA to Bedside: US Regulatory Trends for New Stem Cell Therapies
The phrase “bench to bedside” is commonly used to describe the translation of basic discoveries such as those on stem cells to the clinic for therapeutic use in human patients. However, there is a key intermediate step in between the bench and the bedside involving governmental regulatory oversight...
Na minha lista:
| Publicado no: | Adv Drug Deliv Rev |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4398607/ https://ncbi.nlm.nih.gov/pubmed/25489841 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.addr.2014.12.001 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|